Skip to main content
1721 results

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued

https://www.certara.com/pressrelease/certara-launches-cloud-platform-to-further-unify-its-end-to-end-scientific-software-platform/

Certara Announces New Corporate Headquarters

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – April 15, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued

https://www.certara.com/announcement/certara-announces-new-corporate-headquarters/

What are biosimilars & how are they developed?

Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies demonstrate their bioequivalence to approved biosimilars.

https://www.certara.com/blog/what-are-biosimilars-how-are-they-developed/

Chemicals

The chemicals industry has achieved remarkable innovations in various areas such as biodegradables, advanced battery materials, sustainable green energy solutions and additives to make carbon reduction processing in industrial uses. They are focused on recombining nature’s molecules to invent exciting new things and refine applications for existing products and components (as stated by Joshua Greenbaum, … Continued

https://www.certara.com/chemicals/

Enhancing Regulatory Writing: The Power of Style Guides

TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style conventions unnecessary and time-consuming. However, the industry now recognizes its benefits for maximizing efficiency during regulatory submission development.  The benefits of using style guides and lexicons in medical writing include:  The Certara Drug Development Solutions Document Quality group is experienced in creating and maintaining style guides and … Continued

https://www.certara.com/video/enhancing-regulatory-writing-the-power-of-style-guides/

Molecular Glue Drug Development Summit 2024 Recap

Transcript: Hello, and welcome to Certara Talks. I’m Doctor Suzanne Minton, and I’m a director of content strategy at Certara . Today, I’m talking to my colleague, doctor Joshua Apgar. Joshua, welcome to Certara talks. Would you like to introduce yourself? Sure. Thank you. I’m, Josh Apgar, one of the co founders at applied Balmain, … Continued

https://www.certara.com/video/molecular-glue-drug-development-summit-2024-recap/

CRF Design Checklist

Create effective CRFs using our comprehensive design checklist Simple yet effective Case Report Forms (CRFs) are crucial to the success of a clinical trial. Quality CRFs reduce the chance of mistakes or ambiguity in collected data, or redundant data collection. Our CRF design checklist can help you create high quality CRFs that meet all the requirements … Continued

https://www.certara.com/fact-sheet/crf-design-checklist/

Thank You – Content Download – Pinnacle 21

How about a free demo of Pinnacle 21 Clinical Data Management & Automation Suite? Complete the form to book your no-obligation demo of Pinnacle 21… and see how you can increase the speed and quality of your clinical trial submission data! Trusted by leading drug developers

https://www.certara.com/thank-you-content-download-pinnacle-21/

Supporting the Approval of a Treatment for a Neglected Tropical Disease

In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued

https://www.certara.com/video/supporting-the-approval-of-a-treatment-for-a-neglected-tropical-disease/
2 of 173